CFG
WST icon

Citizens Financial Group’s West Pharmaceutical WST Stock Holding History

Citizens Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-613
Closed -$201K – 652
2024
Q4 		$201K Buy
+613
New +$193K ﹤0.01% 560
2023
Q2 		– Sell
-689
Closed -$239K – 471
2023
Q1 		$239K Buy
+689
New +$201K 0.01% 405
2020
Q3 		– Sell
-112
Closed -$25K – 948
2020
Q2 		$25K Buy
112
+87
+348% +$17.1K ﹤0.01% 591
2020
Q1 		$4K Hold
25
– – ﹤0.01% 912
2019
Q4 		$4K Buy
+25
New +$3.64K ﹤0.01% 908

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Citizens Financial Group's WST Position: Q1 2025 in Review

Citizens Financial Group sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 613 shares — an estimated $201K sold.

Citizens Financial Group first reported a position in WST in Q4 2019 and held it in 5 quarters. The position peaked at $239K in Q1 2023. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Citizens Financial Group reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Citizens Financial Group sold 613 West Pharmaceutical shares in Q1 2025, an estimated $201K.
  • Citizens Financial Group first reported a position in West Pharmaceutical in Q4 2019 and held it in 5 quarters.
  • Citizens Financial Group's West Pharmaceutical position peaked at $239K in Q1 2023.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Citizens Financial Group's 13F filing for Q1 2025, filed 9 May 2025.